It was recently reported that the lymphocyte–CRP ratio (LCR), a novel prognostic score based on the preoperative lymphocyte count and CRP, has emerged as an independent indicator of poor prognosis in various cancers, including colorectal cancer (17), gastric cancer (18), and hepatocellular carcinoma (19). This evidence concerns the gene CRP and hepatocellular carcinoma.